Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Scheifele

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Canada Diseases Weekly Report = Rapport Hebdomadaire Des Maladies Au Canada|April 13, 1991
Evaluation of poliovirus-related cases occurring in Canada in 1989R Gold, D Scheifele, M Fast, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|June 30, 1993
Decline in Haemophilus influenzae type B invasive infections at five Canadian pediatric centresD Scheifele, R Gold, B Law, et al.
Canada Diseases Weekly Report = Rapport Hebdomadaire Des Maladies Au Canada|July 15, 1989
Post-marketing surveillance of adverse events following ProHIBit vaccine--British ColumbiaW Meekison, M Hutcheon, R Guasparini, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 17, 2009
Children hospitalized with influenza during the 2006-2007 season: a report from the Canadian Immunization Monitoring Program, Active (IMPACT)C Burton, W Vaudry, D Moore, et al.
The Pediatric Infectious Disease Journal|May 1, 1994
Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of ageR Gold, D Scheifele, L Barreto, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|January 30, 1994
Meningococcal disease in children hospitalized at six Canadian pediatric tertiary care centresR Gold, P Déry, S Halperin, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|February 28, 1994
Pertussis in children hospitalized at five Canadian pediatric tertiary care centresR Gold, P Déry, S Halperin, et al.
Canada Diseases Weekly Report = Rapport Hebdomadaire Des Maladies Au Canada|September 16, 1989
Evaluation of Canadian poliovirus-related casesR Gold, D Scheifele, W L Albritton, et al.
The Pediatric Infectious Disease Journal|September 24, 1999
Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of ageS A Halperin, D Scheifele, L Barreto, et al.
The Journal of Infectious Diseases|May 1, 1993
Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with congenital aspleniaS A Webber, G G Sandor, M W Patterson, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Canada Diseases Weekly Report = Rapport Hebdomadaire Des Maladies Au Canada|April 13, 1991
Evaluation of poliovirus-related cases occurring in Canada in 1989R Gold, D Scheifele, M Fast, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|June 30, 1993
Decline in Haemophilus influenzae type B invasive infections at five Canadian pediatric centresD Scheifele, R Gold, B Law, et al.
Canada Diseases Weekly Report = Rapport Hebdomadaire Des Maladies Au Canada|July 15, 1989
Post-marketing surveillance of adverse events following ProHIBit vaccine--British ColumbiaW Meekison, M Hutcheon, R Guasparini, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 17, 2009
Children hospitalized with influenza during the 2006-2007 season: a report from the Canadian Immunization Monitoring Program, Active (IMPACT)C Burton, W Vaudry, D Moore, et al.
The Pediatric Infectious Disease Journal|May 1, 1994
Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of ageR Gold, D Scheifele, L Barreto, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|January 30, 1994
Meningococcal disease in children hospitalized at six Canadian pediatric tertiary care centresR Gold, P Déry, S Halperin, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|February 28, 1994
Pertussis in children hospitalized at five Canadian pediatric tertiary care centresR Gold, P Déry, S Halperin, et al.
Canada Diseases Weekly Report = Rapport Hebdomadaire Des Maladies Au Canada|September 16, 1989
Evaluation of Canadian poliovirus-related casesR Gold, D Scheifele, W L Albritton, et al.
The Pediatric Infectious Disease Journal|September 24, 1999
Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of ageS A Halperin, D Scheifele, L Barreto, et al.
The Journal of Infectious Diseases|May 1, 1993
Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with congenital aspleniaS A Webber, G G Sandor, M W Patterson, et al.
Pageof 6